Drug recall · April 9, 2025
Tolterodine Tartrate Extended-Release Capsules recall
Why: Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.
- Lots / codes
Lot# T05393, Exp. Date: 09/30/2025
- Quantity
- 224 cartons
- Company
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories, La Vergne, TN
- Distribution
- Nationwide in the USA
- Initiated
- March 4, 2025 · Voluntary: Firm initiated
- Classified
- March 28, 2025
- Reported
- April 9, 2025
- Ended
- February 23, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tolterodine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.